πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8282926

CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapept

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8278083

Inactivated influenza virus compositions

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8278458

Desferrithiocin polyether analogues

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8278348

Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8278272

GLP-1, exendin-4, peptide analogs and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8278246

Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8278100

Lasonolide compounds as reagents for inducing premature chromosome condensation and method

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8273797

Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehy

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8273724

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268602

Cellular and viral inactivation

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268894

Compositions and methods for the treatment of infectious diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268890

Method of treating ischemia/reperfusion injury with nitroxyl donors

The United States of America, as represented by the Secretary, Health and Human Services Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268615

Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypep

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268323

Conformationally stabilized HIV envelope immunogens

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8263759

Sets of probes and primers for the diagnosis of select cancers

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8263091

Method of treating and preventing infections in immunocompromised subjects with immunostim

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8258106

Immunostimulatory nucleic acid molecules

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8258280

Plasmodium vivax hybrid circumsporozoite protein and vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8258278

Methods and compositions for the treatment and prevention of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8257915

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosc

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252291

Bacteriocins and novel bacterial strains

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252845

Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isofo

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252550

Targeting poly-Ξ³-glutamic acid to treat Staphylococcus epidermidis and related infections

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252545

Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted